Find-A-Study

A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease

Purpose

Category

Aging and Geriatric
Urinary Tract and Kidney

IRB Number: 20220167HU
NCT Number: -
Open to Enrollment: Yes
Sponsor: -

Study Contact

Manoj Bhattarai
(210) 567-4700
bhattaraim@uthscsa.edu

Principal Investigator
Manoj Bhattarai

Manoj Bhattarai
(210) 567-4700
bhattaraim@uthscsa.edu

Andrea Hansis-diarte
+1 (210) 617-5300
hansisdiarte@uthscsa.edu

Italia Herrera
(210) 567-2687
herrerai1@uthscsa.edu

Johnnie Jones
(210) 450-7277
jonesj21@uthscsa.edu

Lorannys Sanchez Tamarez
(210) 450-8332
sancheztamar@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups